1
Strategy overview
2Group financials
2
AGENDA
3
Backup
STRATEGY OVERVIEW
Philippe Donnet
Group Chief Executive Officer
HIGHLIGHTS
Record-high Operating Result at €8 Bn (+9.7% yoy) with positive contribution from all business segments
Excellent P&C performance with strong technical profitability leading to 20% Operating Result growth
Best-in-class Life Net Inflows at €13.5 Bn, with over 80% from Protection & Health and Hybrid & Unit Linked. New Business Value at €3.1 Bn (+6.2% yoy). Life CSM at €33.6 Bn (+11% yoy)
Total Group AUM at €900 Bn, with €384 Bn managed for Third-Party Clients. Asset Management
Operating Result up by 7.5% yoy thanks to the contribution of Conning Holdings Limited
Highest ever adjusted Net Result at €4.3 Bn (+14.5% yoy). Adjusted EPS of €2.85 (+16.2% yoy), reflecting strong underlying business performance and ongoing focus on value creation
Extremely solid Solvency 2 ratio at 219%, supported by healthy normalized capital generation
Proposed DPS of €1.64 (+14.7% yoy) and new €500 Mn share buyback for 2026, reflecting the ongoing
commitment to growing shareholder returns
OUTSTANDING START TO "LIFETIME PARTNER 27: DRIVING EXCELLENCE"
STRONG EARNINGS
PER SHARE GROWTH
8-10%
EPS CAGR1
2024-2027
SOLID CASH
GENERATION
>€11 Bn
Cumulative Net Holding Cash Flow2
2025-2027
INCREASING
DIVIDEND PER SHARE
>10%
DPS CAGR2,3 2024-2027
with a ratchet policy
16.2%
EPS CAGR 2025 vs 2024
€3.8 BnNet Holding Cash Flow 2025
13.2%€1.64 DPS4 in 2026
vs €1.28 LTP27 plan
baseline
3-year CAGR based on the Group's Adjusted Net Result
Expressed on cash basis
3-year CAGR with baseline for Lifetime Partner 2027 Plan at €1.28 per share
Subject to all relevant approvals
STRONG COMMITMENT TO GROWING SHAREHOLDER RETURNS
DIVIDEND AT €1.64 AND NEW €500 MN BUYBACK PROPOSALS UNDERPIN
Dividend Per Share (DPS)
(€)
1.47
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
0.50
0.461
1.01
1.64
0.80
0.85
0.90
1.07
1.16
1.282
1.43
Proposed DPS up 14.7% yoy to €1.643
Annual General Meeting: April 23rd, 2026
Ex-dividend date: May 18th, 2026
Payment date: May 20th, 2026
Proposed New €500 Mn share buyback3
The Dividend Per Share of €1.47 proposed for the 2020 financial year was split into two tranches of €1.01 and €0.46. The first tranche represented the ordinary pay-out from 2020 earnings while the second one was related to the second part of the 2019 dividend, which was retained due to supervisory recommendations during the Covid-19 pandemic
Baseline for Lifetime Partner 2027 Plan
Subject to all the relevant approvals
RECORD-HIGH RESULTS ACROSS OPERATING AND ADJUSTED NET METRICS
Operating Result
(€ Mn)
2024
2025
7,295
8,004
+9.7%
3,769 | 4,315 | 2.45 | 2.85 | |||
2024 | 2025 | 2024 | 2025 | |||
Adjusted Net Result
(€ Mn)
+14.5%
Asset Management Operating Result
(€ Mn)
616
662
+7.5%
Adjusted Earnings per Share
(€)
+16.2%
P&C Operating Result
(€ Mn)
3,052
3,663
+20.0%
Life Net Inflows
(€ Mn)
13,487
9,674
+42.5%
2024 2025
2024 2025
2024 2025
ACCELERATING GROWTH IN OPERATING RESULT
Operating Result1
(€ Mn)
+9.7%
+7.4%
8,004
+5.8%
+8.2%
CAGR
4,857
5,192
5,208
5,852
6,374
6,742
7,295
2018 2019 2020 2021 2022 2023 2024 2025
Data 2018-2021 as disclosed based on historical IFRS4, since 2022 based on IFRS17
PRICE AND VOLUME EFFECTS SUPPORT P&C GROWTH
Europ Assistance: 14.7% yoy growth mainly driven by Volume effect, Price effect broadly in line with what is observed in Retail and SME
2025 P&C Gross Written Premiums (%) 2025 Price and Volume effects
Group GWP €36.2 Bn
36%
33%
10%
6%
15%
Motor
Non-Motor Retail/SME Accident, Health and Disability Europ Assistance
Corporate & Commercial
RETAIL + SME: 84%
Price and Volume % Change (FY25 vs FY24) | Price effect | Volume effect |
Retail and SME1,2 | +4.7% | +1.2% |
o/w Motor | +5.0% | +0.1% |
o/w Non-Motor | +4.1% | +1.6% |
o/w Accident, Health & Disability | +5.3% | +2.7% |
The scope of the analysis is equal to ~90% of the Group P&C Retail + SME business in force at YE25, and excludes Europ Assistance and Argentina
Price effect measured as the yoy change of the Average Annual Premium for risks in-force at the date of observation; Volume effect measured as the yoy change of the risks in-force at the date of observation
EXCELLENT UNDERLYING TECHNICAL PROFITABILITY IN P&C
Undiscounted Operating Insurance Service Result
€2 Bn
in 2025
+50%
year-on-year growth
vs. 2024
33.8 | 36.2 | 95.9 | 94.3 | |||
2024 | 2025 | 2024 | 2025 | |||
P&C Gross Written Premiums
(€ Bn)
Undiscounted COR
(%)
+7.6%1
-1.6 p.p.
Delta percentage change on a like-for-like basis: constant perimeter and exchange rates
STRONG UNDERWRITING DISCIPLINE IN LIFE NEW BUSINESS
28%
NBP w/o guarantee
NBP with guarantee
72%
Reinvestment yield
3.7%
Average guarantee on
guarantee-linked NBP
>300 bps
0.6%
Reserves w/o financial guarantee
Guarantee-linked reserves
44%
56%
Current return
3.4%
Average guarantee on
guarantee-linked reserves1
>220 bps
1.1%
Breakdown of Life reserves
Breakdown of Life New Business Premiums (NBP)
2024 | 2025 | |
Capital Light share on Life reserve2 | 72% | 73% |
2024 | 2025 | |
Life Net Inflows (€ Mn) | 9,674 | 13,487 |
Calculated on General Account
After minorities
PROTECTION, HEALTH & ACCIDENT IS A KEY FOCUS AREA OF LTP27 PLAN
2025 Gross Written Premiums (€98.1 Bn)
Savings, Pension & Unit Linked1
€46.5 Bn
Protection,
Health
& Accident
€21.4 Bn
Motor
& Non-Motor2
€30.2 Bn
Health & Accident5 (P&C)
ca. 28%
Health4 (Life) ca. 29%
Protection3 (Life)
ca. 43%
Steady growth in Protection & Health in all geographies
Acceleration in Health lines, leveraging market demand and focused distribution
PVNBP of Protection riders included in Traditional Savings, Hybrid & Unit Linked reached €1.9 Bn in 2025
PH&A Net Insurance Service Result6 reaching
€1.9 Bn in 2025 (+11% yoy), with a Proxy CoR7 of ca. 90%
Excludes Protection & Health riders allocated to the "Life - Traditional Savings" and "Life - Hybrid & UL" reporting lines
Excludes Health & Accident
Death, Disability, Critical Illness and Long-Term Care. Includes the Protection component of the "Life - Protection & Health" reporting line, plus the Protection riders allocated to the "Life - Traditional Savings" and "Life - Hybrid & UL" reporting lines
Medical Expenses. Includes the Health component of the "Life - Protection & Health" reporting line, plus the Health riders allocated to the "Life - Traditional Savings" and "Life - Hybrid & UL" reporting lines
Includes Medical Expenses, Income Protection and Workers Compensation allocated to P&C
PH&A Net Insurance Service Result Lifetime Partner 2027 Plan target: >€2 Bn, with CAGR 2024-2027 >7%
Calculated as 1-("Net Insurance Service Result" / "Gross Insurance Revenue")
DRIVING EXCELLENCE IN PROTECTION, HEALTH & ACCIDENT
ACCELERATED BUSINESS GROWTH
Distribution & Service focus
Increase distribution network activation and health service scale-up
Focus on increasing distribution network activation
Launch of new health value propositions for target segments
Europ Assistance to setup Health Service Factory to scale-up
top-quality service across BUs
AUGMENTED TECHNICAL PROFICIENCY
Technical
Excellence
Scale distinctive capabilities to strengthen profitability
Steady focus on insurance discipline and capabilities
Structured monitoring of key global trends (e.g.; longevity) to be translated into business-impact initiatives
Group Data Platform & Demographic Hub
Central assets with cross-functional impact
ENHANCED
EFFECTIVENESS
AI & Automation
Leverage GenAI & Data to expand automation across the Group
Expanded Claims and Underwriting automation
Leverage central assets and Gen-AI
Focus on customer satisfaction
AI used also to generate business insights
CONTINUED STRATEGIC DEVELOPMENT OF ASSET & WEALTH MANAGEMENT
A&WM Contribution to Group Operating Result
(%)
2016
2025
8%
15%
+7 p.p.
€384 Bn of Third-Party AUM at FY25, from around €50 Bn a
decade ago
Life and Asset Management relationship continues to deliver healthy synergies, with ca. 2/3 of Unit Linked flows managed by the Group's AM companies
Banca Generali surpassed €110 Bn of Total AUM. Insurbanking initiative to deliver additional benefits for the Group in the coming years
ONGOING COMMITMENT TO LIFETIME PARTNER AMBITION
#1 Position R-NPS¹ Multiholding Customer Base
Generali
Peer 1
Peer 2
Peer 3
22.4
21.3
18.4
15.2
(Mn)
2025
2027
Target
24
22.6
1. RNPS Research (2019-2025), covering 23 countries and 1,212,000 respondents.
AI & DATA DRIVEN EXCELLENCE: KEY HIGHLIGHTS
Generali has set its ambition for run-rate operating result benefit enabled by Artificial
Intelligence to more than €350 Mn by 2027, with expected further acceleration beyond 2027
SCALE APPLICATION ACROSS PROCESSES AND BUSINESSES
The plan is anchored in the scaled deployment of 16 flagship AI use cases across the entire Group, designed to transform core functions
In addition, new disruptive (agentic) AI use cases are being scouted and tested, also through partnerships with leading research institutions such as the MIT
The strong innovation commitment has already delivered effective Agentic AI applications in Claims Management, Agentic Coding and the development of the first AI Agents
Very significant workforce enablement effort on AI/GenAI with targeted hiring and training
AI & DATA DRIVEN EXCELLENCE: STRONG PROGRESS IN 2025
AI & Data Excellence Program
Deployment of 16 AI/GenAI flagship use cases at scale, powered by global AI engines
Identification of new disruptive (agentic) AI/GenAI applications, also through strategic collaboration with MIT
GenAI at scale for personal productivity
Appropriate AI organization and seamless access to Group capabilities for all Business Units
Common platforms (Group Data Platform, agentic
platform) and Group-wide AI governance processes GenAI upskilling across all functions and business areas
2025 Key Achievements
ca. €100 Mn
bottom-line run rate impact from AI/GenAI unlocked at FY25
ca. 60%
global flagship applications live today (>90% planned for 2027)
>75
AI apps live on the Group platform at FY25, generating >20 Mn API calls/month, adopted by 27 Business Units through global AI engines
7
new use cases within the MIT collaboration, paving the way for new or enhanced global AI engines by 2027
>3,000
software developers equipped with GenAI tools and over 15,000 employees trained on GenAI
16 AI/GENAI FLAGSHIP USE CASES TRANSFORMING OUR VALUE CHAIN
PRICING
UNDERWRITING
END-TO-END CLAIMS
SMART OPERATIONS
KEY PRINCIPLES
Focus on use cases with adoption by design
No pilots with unclear benefits
Predictive models and automation are still key drivers of impact, with GenAI leading new wave of opportunities through Agentic AI
P&C pricing sophistication with machine learning based elasticity and multi-year profit optimization
Market pricing intelligence
Advanced weather risks models (e.g., hail, windstorm), also with geospatial analytics
Intelligent documents processing for underwriting automation - risk scoring, policy drafting
Geo intelligence for insured value assessment from AI-extracted building features like floor size, height
Geo intelligence for risk profiling, from AI processed vulnerability features like roof shape/orientation, building material, solar panels
Motor docs processing - data extraction from accident forms, authority reports
Non-Motor docs processing -repair invoices, estimates
Health claims settlement automation - extract data from receipts, classify treatments, auto-settlement
Intelligent steering - route to most cost-effective repairer
Automated damage assessment - image-based ML assessment of vehicle damage
Advanced fraud detection, combining ML with AI agents e.g., for docs/image processing
Claims handling assistant/ agentic claim - end-to-end agentic orchestration of complex claim summaries, expert evaluations and next best actions
Automatic processing of inbound flows - AI extracts, classifies, and routes emails, forms, and unstructured docs
Inbound phone calls end-to-end automation, through conversational GenAI agents
GenAI for IT/software development (agentic chain for coding, automated testing)
AI IMPLEMENTATION IS REVOLUTIONARY FOR OUR CLAIMS MANAGEMENT
Automatic opening of claims (from email, voice bot, webapp - including image acquisition) and document processing (e.g., extracts >50 data fields and unstructured data from accident reports or repair invoices)
Automatic triage to best handling process (cash, repair, total loss)
Intelligent steering to most cost-effective repairer (e.g., compares thousands of granular spare parts and labor rates across repairers)
Damage detection/assessment with image analytics (e.g., analyses >20 different vehicle panels for damage classification)
Fraud detection, also with GenAI on docs/images
Agentic AI for end-to-end automated claims handling, including a GenAI
"digital buddy" for human handler assistance
LONG-TERM RUN RATE POTENTIAL
>40%
efficiency/productivity gain with AI and Agentic AI
-80%
handling time reduction
+3%
claims payout reduction
BEYOND FLAGSHIP INITIATIVES: SCALING AGENTIC AI, INNOVATION AND BUSINESS INSIGHTS FACTORY
FULL SCALE AGENTIC AI DEPLOYMENT
Accelerate the shift from AI assistants to end-to-end autonomous agents across key functions (e.g. claims handling, IT coding, customer service), progressively extending to the whole insurance value chain
Industrialise deployment through Group Agentic Platform to ensure compliance, reuse and cost efficiency
DEPLOYMENT OF GENERATIVE AI INNOVATION AND INSIGHT FACTORY
Advance new GenAI apps beyond the 16 flagship use cases to create a competitive advantage
in the medium term in strategic areas (e.g., environment & health risk intelligence)
Prioritise industrialization of the most promising apps on Group platforms to enable rapid cross-BU adoption
Industrialise cross-BU analytics on the expanding Group Data Platform - through a Global Insight Factory that converts Group-wide data into reusable insights and data products powered by AI agents
ENHANCING ADVISORS PRODUCTIVITY THROUGH DIGITAL TOOLS AND AGENTIC AI
Make our digital channels accessible to AI tools and our products easily machine readable, to protect and increase our visibility in the new AI world
Augment our insurance agents productivity through LLMs (e.g., pre-qualified leads with clearer intent, faster needs analysis and better explanation of coverage and exclusions)

